These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32531361)

  • 1. Self- assembled lactoferrin-conjugated linoleic acid micelles as an orally active targeted nanoplatform for Alzheimer's disease.
    Agwa MM; Abdelmonsif DA; Khattab SN; Sabra S
    Int J Biol Macromol; 2020 Nov; 162():246-261. PubMed ID: 32531361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boosted Memory and Improved Brain Bioavailability of Rivastigmine: Targeting Effort to the Brain Using Covalently Tethered Lower Generation PAMAM Dendrimers with Lactoferrin.
    Gothwal A; Nakhate KT; Alexander A; Ajazuddin ; Gupta U
    Mol Pharm; 2018 Oct; 15(10):4538-4549. PubMed ID: 30156844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer's Disease in Mice.
    Gothwal A; Kumar H; Nakhate KT; Ajazuddin ; Dutta A; Borah A; Gupta U
    Bioconjug Chem; 2019 Oct; 30(10):2573-2583. PubMed ID: 31553175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of lactoferrin-coated multifunctional copolymer micelles to cross the blood-brain barrier.
    Ouyang N; Yang C; Li X; Zheng Z; Xu Y; Wang Y; Xiong W; Wu H
    Drug Deliv Transl Res; 2024 Mar; 14(3):773-787. PubMed ID: 37721695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer's disease: pharmaceutical, biological, and toxicological studies.
    Elnaggar YS; Etman SM; Abdelmonsif DA; Abdallah OY
    Int J Nanomedicine; 2015; 10():5459-73. PubMed ID: 26346130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugated linoleic acid downregulates Alzheimer's hallmarks in aluminum mouse model through an Nrf2-mediated adaptive response and increases brain glucose transporter levels.
    Cuciniello R; Luongo D; Ferramosca A; Lunetti P; Rotondi-Aufiero V; Crispi S; Zara V; Maurano F; Filosa S; Bergamo P
    Free Radic Biol Med; 2022 Oct; 191():48-58. PubMed ID: 36028179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain targeting of 9c,11t-Conjugated Linoleic Acid, a natural calpain inhibitor, preserves memory and reduces Aβ and P25 accumulation in 5XFAD mice.
    Binyamin O; Nitzan K; Frid K; Ungar Y; Rosenmann H; Gabizon R
    Sci Rep; 2019 Dec; 9(1):18437. PubMed ID: 31804596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembled polymersomes conjugated with lactoferrin as novel drug carrier for brain delivery.
    Yu Y; Pang Z; Lu W; Yin Q; Gao H; Jiang X
    Pharm Res; 2012 Jan; 29(1):83-96. PubMed ID: 21979908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified Ce/Zr-MOF Nanoparticles Loaded with Curcumin for Alzheimer's Disease via Multifunctional Modulation.
    Yang Y; Wang Y; Jiang X; Mi J; Ge D; Tong Y; Zhu Y
    Int J Nanomedicine; 2024; 19():9943-9959. PubMed ID: 39355653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer.
    Sabra SA; Elzoghby AO; Sheweita SA; Haroun M; Helmy MW; Eldemellawy MA; Xia Y; Goodale D; Allan AL; Rohani S
    Eur J Pharm Biopharm; 2018 Jul; 128():156-169. PubMed ID: 29689288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
    Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
    Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route.
    Jiang Y; Liu C; Zhai W; Zhuang N; Han T; Ding Z
    Int J Nanomedicine; 2019; 14():9217-9234. PubMed ID: 31819426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-Targeting Lactoferrin-Conjugated Polymerized Magnetic Polydiacetylene-Assembled Nanocarriers with Self-Responsive Fluorescence/Magnetic Resonance Imaging for In Vivo Brain Tumor Therapy.
    Fang JH; Chiu TL; Huang WC; Lai YH; Hu SH; Chen YY; Chen SY
    Adv Healthc Mater; 2016 Mar; 5(6):688-95. PubMed ID: 26820074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of brain-targeted polymeric nanocarriers (Frankincense-PMBN-lactoferrin) and in-vivo evaluation on an Alzheimer's disease-like rat model induced by scopolamine.
    Moazzam F; Hatamian-Zarmi A; Ebrahimi Hosseinzadeh B; Khodagholi F; Rooki M; Rashidi F
    Brain Res; 2024 Jan; 1822():148622. PubMed ID: 37832760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced brain delivery of deferasirox-lactoferrin conjugates for iron chelation therapy in neurodegenerative disorders: in vitro and in vivo studies.
    Kamalinia G; Khodagholi F; Atyabi F; Amini M; Shaerzadeh F; Sharifzadeh M; Dinarvand R
    Mol Pharm; 2013 Dec; 10(12):4418-31. PubMed ID: 24063264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
    Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
    J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
    Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
    J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection against apoptosis of SK-N-MC cells using RMP-7- and lactoferrin-grafted liposomes carrying quercetin.
    Kuo YC; Tsao CW
    Int J Nanomedicine; 2017; 12():2857-2869. PubMed ID: 28435263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer's disease using Box-Behnken design.
    Jojo GM; Kuppusamy G; De A; Karri VVSNR
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1061-1072. PubMed ID: 30922126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of morin hydrate-loaded micellar nanocarriers for the effective management of Alzheimer's disease.
    Singh M; Thakur V; Deshmukh R; Sharma A; Rathore MS; Kumar A; Mishra N
    J Microencapsul; 2018 Mar; 35(2):137-148. PubMed ID: 29448848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.